Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
STAAR SURGICAL CO (STAA)
|
Add to portfolio |
|
|
|
| Price: |
$93.50
| | Metrics |
| OS: |
48.5
|
M
| |
|
|
| Market cap: |
$4.53
|
B
| |
|
|
|
Net cash:
|
$94.7
|
M
| |
$1.95
|
per share
|
|
EV:
|
$4.44
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$41.8
|
M
| |
106.3
|
x EV/EBITDA
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Jan-01-21 | Jan-03-20 | Dec-28-18 | Dec-29-17 | Dec-30-16 | Jan-01-16 | Jan-02-15 |
| Revenues | 230.5 | 163.5 | 150.2 | 22.9 | 22.3 | 82.4 | 77.1 | 75.0 |
| Revenue growth | 41.0% | 8.8% | 556.6% | 2.6% | -73.0% | 6.9% | 2.8% | 3.8% |
| Cost of goods sold | 51.8 | 45.1 | 38.2 | 32.4 | 26.3 | 24.1 | 24.4 | 26.2 |
| Gross profit | 178.6 | 118.4 | 112.0 | -9.6 | -4.0 | 58.4 | 52.7 | 48.8 |
| Gross margin | 77.5% | 72.4% | 74.5% | -41.9% | -18.2% | 70.8% | 68.4% | 65.1% |
| Sales and marketing | 67.3 | 45.8 | 45.5 | 38.6 | 28.4 | 28.7 | 23.7 | 25.9 |
| Research and development | 33.9 | 31.9 | 25.3 | 22.0 | 20.0 | 20.7 | 14.8 | 12.4 |
| General and administrative | 44.1 | 33.9 | 29.3 | 24.3 | 19.5 | 21.7 | 19.6 | 18.6 |
| EBITA | 33.4 | 7.0 | 11.9 | 6.6 | -2.8 | -12.4 | -5.1 | -7.6 |
| EBITA margin | 14.5% | 4.3% | 7.9% | 29.0% | -12.6% | -15.1% | -6.7% | -10.2% |
| Amortization of intangibles | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | 0.2 | 0.4 |
| EBIT | 33.3 | 7.0 | 11.9 | 6.6 | -3.0 | -12.7 | -5.3 | -8.0 |
| EBIT margin | 14.5% | 4.3% | 7.9% | 28.8% | -13.6% | -15.4% | -6.9% | -10.7% |
| Pre-tax income | 31.3 | 8.3 | 13.0 | 6.6 | -2.3 | -12.4 | -5.6 | -8.6 |
| Income taxes | 6.8 | 2.4 | -1.0 | 1.7 | -0.2 | -0.3 | 0.9 | -0.3 |
| Tax rate | 21.7% | 28.5% | | 25.2% | 6.8% | 2.5% | | 2.9% |
| Net income | 24.5 | 5.9 | 14.0 | 5.0 | -2.1 | -12.1 | -6.5 | -8.4 |
| Net margin | 10.6% | 3.6% | 9.4% | 21.7% | -9.6% | -14.7% | -8.5% | -11.2% |
| |
| Diluted EPS | $0.50 | $0.12 | $0.30 | $0.11 | ($0.05) | ($0.30) | ($0.17) | ($0.22) |
| Shares outstanding (diluted) | 49.5 | 48.0 | 46.9 | 45.3 | 41.0 | 40.3 | 39.3 | 38.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|